Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases by targeting molecular pathways.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. J. Warren Huff$755.1M
Market Cap • 09/05/20222002
(há 22 anos)
2016
(8 years ago)
NASDAQ
Listagem
Plano
Sede • Texas323
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
RETASó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.